Literature DB >> 9120653

Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults.

K L Nichol1, R Mac Donald, M Hauge.   

Abstract

OBJECTIVE: This cross-sectional survey assessed factors associated with influenza and pneumococcal vaccination behaviors among high-risk patients exposed to highly organized vaccination programs.
INTERVENTIONS: Self-administered questionnaires were mailed to 700 patients randomly selected from the outpatient roster of the medical center. Questions were asked about patient demographic and health characteristics in addition to their knowledge and attitudes regarding influenza and pneumococcal diseases and vaccines. MAIN
RESULTS: After three mailings, the response rate was 68%, and 80% of these respondents were in a high-risk ++group. Influenza and pneumococcal vaccination rates for high-risk respondents were 74.4% and 62.5%, respectively. Factors independently associated with both influenza and pneumococcal vaccination behaviors included health care providers' recommendations and having positive attitudes toward immunization. In addition, for influenza vaccination, willingness to comply with the provider's recommendation was also associated with receipt of the vaccine while cigarette smoking was associated with failure to receive the vaccine.
CONCLUSIONS: Emphasis on provider recommendations and the knowledge and attitudes of patients may enhance influenza and pneumococcal vaccination rates, even in the context of organized vaccination programs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9120653     DOI: 10.1007/bf02600158

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

1.  Long-term success with the national health objective for influenza vaccination: an institution-wide model.

Authors:  K L Nichol
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 2.  Immunization policies and vaccine coverage among adults. The risk for missed opportunities.

Authors:  W W Williams; M A Hickson; M A Kane; A P Kendal; J S Spika; A R Hinman
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

3.  Influenza and pneumococcal immunization strategies for physicians.

Authors:  D S Fedson
Journal:  Chest       Date:  1987-03       Impact factor: 9.410

4.  Bias in analytic research.

Authors:  D L Sackett
Journal:  J Chronic Dis       Date:  1979

5.  Adult immunization: knowledge, attitudes, and practices--DeKalb and Fulton Counties, Georgia, 1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-11-04       Impact factor: 17.586

6.  Adult immunization. Summary of the National Vaccine Advisory Committee Report.

Authors:  D S Fedson
Journal:  JAMA       Date:  1994-10-12       Impact factor: 56.272

7.  Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-14       Impact factor: 17.586

8.  Patient acceptance of influenza vaccination.

Authors:  N H Fiebach; C M Viscoli
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965

Review 9.  Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.

Authors:  N Fiebach; W Beckett
Journal:  Arch Intern Med       Date:  1994-11-28

10.  Improving influenza vaccination rates for high-risk inpatients.

Authors:  K L Nichol
Journal:  Am J Med       Date:  1991-12       Impact factor: 4.965

View more
  49 in total

Review 1.  Increasing immunization rates among African-American adults.

Authors: 
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

Review 2.  Paved with good intentions: do public health and human service providers contribute to racial/ethnic disparities in health?

Authors:  Michelle van Ryn; Steven S Fu
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

3.  The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries.

Authors:  Paul L Hebert; Kevin D Frick; Robert L Kane; A Marshall McBean
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

4.  Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study.

Authors:  Kendra L Schwartz; Anne Victoria Neale; Justin Northrup; Joseph Monsur; Divya A Patel; Rodrigo Tobar; Pascale M Wortley
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

5.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

6.  Development and testing of a vaccination message targeted to persons with spinal cord injuries and disorders.

Authors:  Sherri L LaVela; Kenzie A Cameron; Michael Priebe; Frances M Weaver
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

7.  Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center.

Authors:  Vincenzo Restivo; Giovanni Vizzini; Alessandra Mularoni; Cinzia Di Benedetto; Santi Mauro Gioè; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2017-02       Impact factor: 3.452

8.  Endorsement of compulsory HIV vaccination policy among populations at high risk of HIV exposure (LA VOICES).

Authors:  Peter A Newman; Sung-Jae Lee; Ellen T Rudy; Allison Diamant; Naihua Duan; Terry Nakazono; Terry Nakazano; William E Cunningham
Journal:  Prev Sci       Date:  2014-06

9.  Multimorbidity is associated with uptake of influenza vaccination.

Authors:  Samantha M Harrison; Melissa Y Wei; Lois E Lamerato; Joshua G Petrie; Emily Toth Martin
Journal:  Vaccine       Date:  2018-05-07       Impact factor: 3.641

10.  Cross-sectional study on influenza vaccination, Germany, 1999-2000.

Authors:  Sybille Rehmet; Andrea Ammon; Günter Pfaff; Nikolaus Bocter; Lyle R Petersen
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.